Search for: "State v. Constantine" Results 121 - 135 of 135
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2014, 5:01 am by Andres
The CJEU has had to analyse blocking orders in the case of UPC Telekabel v Constantin Film & Wega Filmproduktionsgesellschaft  (C‑314/12). [read post]
8 Oct 2010, 2:14 pm by Roshonda Scipio
Munro.Abingdon, Oxon, UK ; New York : Routledge, 2010.Constitutional LawK3161 .F73 2010Framing the state in times of transition : case studies in constitution making / Laurel E. [read post]
1 Oct 2009, 9:46 pm
I am thankful to my friend Eugene White for drawing to my attention a recent case from the ACT where a solicitor, David Landers, had some difficulties in dealing with ACT authorities on behalf of his client, a teacher who wanted to retire and get a payout due to illness.Because of the significance of this decision, I have set out the judgment in full.DAVID LANDER v COUNCIL OF THE LAW SOCIETY OF THE AUSTRALIAN CAPITAL TERRITORY[2009] ACTSC 117 (11 September 2009)APPEAL - Appeal against… [read post]
19 Jun 2022, 5:05 pm by admin
In a seminal discrimination case, Casteneda v. [read post]
23 May 2022, 6:54 am by Dan Lopez
SUBSCRIBE TO OUR PODCAST Episode Transcript and Show Notes: Jeff Shinder: Welcome to Antitrust Matters, a Constantine Cannon podcast, where we have engaging and timely conversations about competition policy in the digital age. [read post]
18 Jan 2023, 11:41 am by Dan Lopez
SUBSCRIBE TO OUR PODCAST Episode Transcript and Show Notes: Jeff Shinder: Welcome to Antitrust Matters, a Constantine Cannon podcast where we have engaging and timely conversations about competition policy in the digital age. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]